Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Chronic methamphetamine self-administration alters cognitive flexibility in male rats.

Cox BM, Cope ZA, Parsegian A, Floresco SB, Aston-Jones G, See RE.

Psychopharmacology (Berl). 2016 Jun;233(12):2319-27. doi: 10.1007/s00213-016-4283-0. Epub 2016 Apr 2.

2.

Neuropsychological Consequences of Chronic Drug Use: Relevance to Treatment Approaches.

Cadet JL, Bisagno V.

Front Psychiatry. 2016 Jan 15;6:189. doi: 10.3389/fpsyt.2015.00189. eCollection 2015. Review.

3.

Abbreviated Goal Management Training Shows Preliminary Evidence as a Neurorehabilitation Tool for HIV-associated Neurocognitive Disorders among Substance Users.

Casaletto KB, Moore DJ, Woods SP, Umlauf A, Scott JC, Heaton RK.

Clin Neuropsychol. 2016;30(1):107-30. doi: 10.1080/13854046.2015.1129437. Epub 2016 Jan 12.

4.

Depression and executive dysfunction contribute to a metamemory deficit among individuals with methamphetamine use disorders.

Casaletto KB, Obermeit L, Morgan EE, Weber E, Franklin DR, Grant I, Woods SP; Translational Methamphetamine AIDS Research Center (TMARC) Group.

Addict Behav. 2015 Jan;40:45-50. doi: 10.1016/j.addbeh.2014.08.007. Epub 2014 Aug 28.

5.

Transcriptional and epigenetic substrates of methamphetamine addiction and withdrawal: evidence from a long-access self-administration model in the rat.

Cadet JL, Brannock C, Jayanthi S, Krasnova IN.

Mol Neurobiol. 2015 Apr;51(2):696-717. doi: 10.1007/s12035-014-8776-8. Epub 2014 Jun 18. Review.

6.

The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans.

Taylor SB, Lewis CR, Olive MF.

Subst Abuse Rehabil. 2013 Feb 8;4:29-43. doi: 10.2147/SAR.S39684. eCollection 2013. Review.

7.

Congenital abnormality effect of methamphetamine on histological, cellular and chromosomal defects in fetal mice.

Mirjalili T, Kalantar SM, Shams Lahijani M, Sheikhha MH, Talebi A.

Iran J Reprod Med. 2013 Jan;11(1):39-46.

8.

"Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency.

Marquine MJ, Iudicello JE, Morgan EE, Brown GG, Letendre SL, Ellis RJ, Deutsch R, Woods SP, Grant I, Heaton RK; Translational Methamphetamine AIDS Research Center (TMARC) Group.

Psychiatry Res. 2014 Jan 30;215(1):208-16. doi: 10.1016/j.psychres.2013.11.004. Epub 2013 Nov 13.

9.

Attention-deficit/hyperactivity disorder among chronic methamphetamine users: frequency, persistence, and adverse effects on everyday functioning.

Obermeit LC, Cattie JE, Bolden KA, Marquine MJ, Morgan EE, Franklin DR Jr, Atkinson JH, Grant I, Woods SP; Translational Methamphetamine AIDS Research Center (TMARC) Group.

Addict Behav. 2013 Dec;38(12):2874-8. doi: 10.1016/j.addbeh.2013.08.010. Epub 2013 Aug 19.

10.

Methamphetamine dependent individuals show attenuated brain response to pleasant interoceptive stimuli.

May AC, Stewart JL, Migliorini R, Tapert SF, Paulus MP.

Drug Alcohol Depend. 2013 Aug 1;131(3):238-46. doi: 10.1016/j.drugalcdep.2013.05.029. Epub 2013 Jun 25.

11.

Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use.

Blackstone K, Iudicello JE, Morgan EE, Weber E, Moore DJ, Franklin DR, Ellis RJ, Grant I, Woods SP; Translational Methamphetamine AIDS Research Center Group.

J Addict Med. 2013 Jul-Aug;7(4):255-63. doi: 10.1097/ADM.0b013e318293653d.

12.

Everyday functional ability across different phases of bipolar disorder.

Henry BL, Minassian A, Perry W.

Psychiatry Res. 2013 Dec 30;210(3):850-6. doi: 10.1016/j.psychres.2013.04.006. Epub 2013 May 2.

13.

Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana.

Sung YH, Carey PD, Stein DJ, Ferrett HL, Spottiswoode BS, Renshaw PF, Yurgelun-Todd DA.

Behav Brain Res. 2013 Jun 1;246:154-61. doi: 10.1016/j.bbr.2013.02.028. Epub 2013 Mar 4.

14.

Perseverative behavior in rats with methamphetamine-induced neurotoxicity.

Son JH, Kuhn J, Keefe KA.

Neuropharmacology. 2013 Apr;67:95-103. doi: 10.1016/j.neuropharm.2012.09.021. Epub 2012 Nov 14.

15.

Hospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophrenia.

Harvey PD, Loewenstein DA, Czaja SJ.

Neurobiol Dis. 2013 May;53:18-25. doi: 10.1016/j.nbd.2012.10.022. Epub 2012 Oct 31. Review.

16.

Decreased frontal lobe phosphocreatine levels in methamphetamine users.

Sung YH, Yurgelun-Todd DA, Shi XF, Kondo DG, Lundberg KJ, McGlade EC, Hellem TL, Huber RS, Fiedler KK, Harrell RE, Nickerson BR, Kim SE, Jeong EK, Renshaw PF.

Drug Alcohol Depend. 2013 Apr 1;129(1-2):102-9. doi: 10.1016/j.drugalcdep.2012.09.015. Epub 2012 Oct 18.

17.

Elevated neurobehavioral symptoms are associated with everyday functioning problems in chronic methamphetamine users.

Cattie JE, Woods SP, Iudicello JE, Posada C, Grant I; TMARC Group.

J Neuropsychiatry Clin Neurosci. 2012 Summer;24(3):331-9. doi: 10.1176/appi.neuropsych.11080192.

18.

An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans.

Dean AC, Groman SM, Morales AM, London ED.

Neuropsychopharmacology. 2013 Jan;38(2):259-74. doi: 10.1038/npp.2012.179. Epub 2012 Sep 5. Review.

19.

Performance on an impulse control task is altered in adult rats exposed to amphetamine during adolescence.

Hankosky ER, Gulley JM.

Dev Psychobiol. 2013 Nov;55(7):733-44. doi: 10.1002/dev.21067. Epub 2012 Jul 6.

20.

Neurocognitive deficits are associated with unemployment in chronic methamphetamine users.

Weber E, Blackstone K, Iudicello JE, Morgan EE, Grant I, Moore DJ, Woods SP; Translational Methamphetamine AIDS Research Center (TMARC) Group.

Drug Alcohol Depend. 2012 Sep 1;125(1-2):146-53. Epub 2012 May 3.

Supplemental Content

Support Center